ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 30 filers reported holding ENZYMOTEC LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,218,000 | +3068.6% | 187,170 | +1662.1% | 0.00% | – |
| Q4 2016 | $70,000 | +100.0% | 10,622 | +112.0% | 0.00% | – |
| Q3 2016 | $35,000 | -65.7% | 5,011 | -59.0% | 0.00% | – |
| Q2 2016 | $102,000 | -79.5% | 12,208 | -77.9% | 0.00% | – |
| Q1 2016 | $498,000 | +4.8% | 55,169 | +13.8% | 0.00% | – |
| Q4 2015 | $475,000 | +246.7% | 48,486 | +219.0% | 0.00% | – |
| Q3 2015 | $137,000 | +87.7% | 15,198 | +73.9% | 0.00% | – |
| Q2 2015 | $73,000 | +192.0% | 8,739 | +152.9% | 0.00% | – |
| Q1 2015 | $25,000 | -77.3% | 3,456 | -75.9% | 0.00% | – |
| Q4 2014 | $110,000 | +214.3% | 14,355 | +178.4% | 0.00% | – |
| Q3 2014 | $35,000 | +105.9% | 5,156 | +319.2% | 0.00% | – |
| Q2 2014 | $17,000 | -93.1% | 1,230 | -89.1% | 0.00% | – |
| Q1 2014 | $248,000 | -23.2% | 11,257 | -5.8% | 0.00% | – |
| Q4 2013 | $323,000 | – | 11,952 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,143,145 | $10,323,000 | 2.59% |
| Visium Asset Management, LP | 2,200,000 | $19,866,000 | 0.34% |
| Paulson & Co. | 4,224,139 | $38,144,000 | 0.28% |
| ALGERT GLOBAL LLC | 20,988 | $190,000 | 0.07% |
| MENTA CAPITAL LLC | 43,126 | $389,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 61,844 | $558,000 | 0.04% |
| Acrospire Investment Management LLC | 2,785 | $25,000 | 0.02% |
| ICON ADVISERS INC/CO | 16,800 | $152,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 168,738 | $1,523,000 | 0.01% |
| Renaissance Technologies | 181,000 | $1,634,000 | 0.00% |